Patents Assigned to Tillotson Healthcare Corporation
  • Patent number: 6380283
    Abstract: A method of treating natural rubber latex to reduce the antigenic protein content includes enzyme treatment of the natural rubber latex and utilizing a chemical stabilizer of the type similar to branched dodecyl benzene sulphonic acid alone or in combination with other stabilizers such as a sulfated fatty acid in combination with hydroxypropyl methylcellulose is disclosed. Also disclosed is a treatment of natural rubber latex with antioxidants either alone or together which ether serve to allow natural rubber latex products to be chlorinated without suffering debilitating aging effects. The first antioxidant is of the type 4,4-(6-T-butyl-M-cresol) or 4,4+-Butylidenebis (3-methyl-6-tert-butylphenol) while the second antioxidant is of the type of a polymeric hindered phenol or butylated reaction product of P-cresol and dicyclopentadiene.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: April 30, 2002
    Assignee: Tillotson Healthcare Corporation
    Inventors: Frank W. Perrella, Joseph K. Pieroni, Thomas N. Tillotson